Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,116 | 6,006 | 12,792 | 5,426 | 3,545 |
| Marketable Securities | 103,020 | 31,504 | 46,184 | 65,994 | 81,219 |
| Receivables | 735 | 1,542 | 939 | 778 | 981 |
| TOTAL | $115,805 | $41,031 | $61,445 | $77,018 | $89,143 |
| Non-Current Assets | |||||
| PPE Net | 1,399 | 1,499 | 1,614 | 1,665 | 1,433 |
| Other Non-Current Assets | 769 | 769 | 769 | 1,469 | 1,469 |
| TOTAL | $2,168 | $2,268 | $2,383 | $3,134 | $2,902 |
| Total Assets | $117,973 | $43,299 | $63,828 | $80,152 | $92,045 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 7,190 | 12,512 | 11,533 | 6,825 | 8,168 |
| TOTAL | $7,190 | $12,512 | $11,533 | $6,825 | $8,168 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,563 | 1,518 | 1,570 | 1,525 | 1,289 |
| TOTAL | $1,563 | $1,518 | $1,570 | $1,525 | $1,289 |
| Total Liabilities | $8,753 | $14,030 | $13,103 | $8,350 | $9,457 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 905 | 903 | 758 | 757 | 757 |
| Common Shares | 33 | 32 | 27 | 27 | 27 |
| Retained earnings | -193,720 | -184,420 | -162,171 | -140,199 | -128,657 |
| Other shareholders' equity | -13 | -86,494 | 3 | 20 | 41 |
| TOTAL | $109,220 | $29,269 | $50,725 | $71,802 | $82,588 |
| Total Liabilities And Equity | $117,973 | $43,299 | $63,828 | $80,152 | $92,045 |